Ventyx Biosciences (VTYX) Short Interest Ratio & Short Volume → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free VTYX Stock Alerts $4.78 -0.03 (-0.62%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Ventyx Biosciences Short Interest DataCurrent Short Interest8,310,000 sharesPrevious Short Interest8,410,000 sharesChange Vs. Previous Month-1.19%Dollar Volume Sold Short$34.82 millionShort Interest Ratio4.0 Days to CoverLast Record DateMay 15, 2024Outstanding Shares70,500,000 sharesFloat Size50,740,000 sharesShort Percent of Float16.38%Today's Trading Volume425,542 sharesAverage Trading Volume628,856 sharesToday's Volume Vs. Average68% Short Selling Ventyx Biosciences ? Sign up to receive the latest short interest report for Ventyx Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVTYX Short Interest Over TimeVTYX Days to Cover Over TimeVTYX Percentage of Float Shorted Over Time Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Ventyx Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20248,310,000 shares $34.82 million -1.2%16.4%4 $4.19 4/30/20248,410,000 shares $31.45 million +0.4%14.8%2.2 $3.74 4/15/20248,380,000 shares $39.13 million -9.1%17.5%2.2 $4.67 3/31/20249,220,000 shares $50.71 million -2.4%19.6%2.2 $5.50 3/15/20249,450,000 shares $72.77 million +2.8%20.1%2.2 $7.70 2/29/20249,190,000 shares $65.07 million +64.4%19.5%2.1 $7.08 Get the Latest News and Ratings for VTYX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ventyx Biosciences and its competitors with MarketBeat's FREE daily newsletter. 2/15/20245,590,000 shares $13.98 million +15.0%11.9%1.4 $2.50 1/31/20244,860,000 shares $10.25 million -2.4%10.9%1.6 $2.11 1/15/20244,980,000 shares $11.11 million -6.9%11.2%1.6 $2.23 12/31/20235,350,000 shares $13.21 million -26.2%N/A0 $2.47 12/15/20237,250,000 shares $16.31 million -1.5%16.3%2.7 $2.25 11/30/20237,360,000 shares $15.90 million +24.5%16.5%3.2 $2.16 11/15/20235,910,000 shares $13.95 million -20.4%13.3%3 $2.36 10/31/20237,420,000 shares $107.00 million -13.9%17.0%4.9 $14.42 10/15/20238,620,000 shares $159.04 million -7.7%19.7%12.1 $18.45 9/30/20239,340,000 shares $324.38 million -1.5%21.4%15.4 $34.73 9/15/20239,480,000 shares $345.07 million +3.3%21.7%15.9 $36.40 8/31/20239,180,000 shares $307.53 million -1.5%20.7%13.9 $33.50 8/15/20239,320,000 shares $285.66 million -0.1%21.0%13.1 $30.65 7/31/20239,330,000 shares $345.68 million -1.0%22.3%13 $37.05 7/15/20239,420,000 shares $337.61 million -4.0%22.5%12.8 $35.84 6/30/20239,810,000 shares $321.77 million +9.6%24.1%11.9 $32.80 6/15/20238,950,000 shares $299.02 million +8.0%22.1%10.6 $33.41 5/31/20238,290,000 shares $285.76 million +7.1%20.5%10 $34.47 5/15/20237,740,000 shares $278.64 million +6.2%19.2%9.1 $36.00 4/30/20237,290,000 shares $274.10 million +7.1%19.2%8.6 $37.60 4/15/20236,810,000 shares $203.28 million -14.8%18.0%7.4 $29.85 3/31/20237,990,000 shares $267.67 million +37.3%22.5%9.5 $33.50 3/15/20235,820,000 shares $217.67 million +14.6%15.9%7.8 $37.40 2/28/20235,080,000 shares $219.71 million +10.2%14.7%6.7 $43.25 2/15/20234,610,000 shares $206.71 million +27.7%13.3%6.4 $44.84 1/31/20233,610,000 shares $151.62 million -12.6%10.2%5.2 $42.00 1/15/20234,130,000 shares $143.60 million +9.3%11.9%6.9 $34.77 12/30/20223,780,000 shares $123.95 million +0.5%11.0%6.6 $32.79 12/15/20223,760,000 shares $125.77 million +9.6%11.3%6.7 $33.45 11/30/20223,430,000 shares $99.44 million +6.5%11.7%4.7 $28.99 11/15/20223,220,000 shares $83.01 million -13.4%11.3%4.8 $25.78 10/31/20223,720,000 shares $120.42 million -6.8%15.1%5.4 $32.37 10/15/20223,990,000 shares $115.43 million +8.1%18.0%6.2 $28.93 9/30/20223,690,000 shares $128.82 million +5.4%16.7%6.1 $34.91SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. 9/15/20223,500,000 shares $131.32 million -20.1%15.8%6 $37.52 8/31/20224,380,000 shares $89.35 million +0.9%19.8%8.7 $20.40 8/15/20224,340,000 shares $80.72 million -1.1%19.4%17.5 $18.60 7/31/20224,390,000 shares $66.33 million +7.1%19.8%22.8 $15.11 7/15/20224,100,000 shares $61.50 million +7.9%18.4%21.8 $15.00 6/30/20223,800,000 shares $46.47 million +18.8%17.1%19.2 $12.23 6/15/20223,200,000 shares $41.82 million +3.6%14.4%16.3 $13.07 5/31/20223,090,000 shares $54.11 million +9.6%13.9%18.4 $17.51 5/15/20222,820,000 shares $42.05 million +8.5%12.7%18.7 $14.91 4/30/20222,600,000 shares $37.78 million -9.7%11.7%18.7 $14.53 4/15/20222,880,000 shares $37.99 million +5.1%13.0%20.4 $13.19 3/31/20222,740,000 shares $37.18 million +11.8%12.5%20.9 $13.57 3/15/20222,450,000 shares $25.73 million +7.9%11.9%20.2 $10.50 2/28/20222,270,000 shares $26.54 million +9.1%11.0%14.5 $11.69 2/15/20222,080,000 shares $25.79 million +5.6%10.1%12.2 $12.40 1/31/20221,970,000 shares $32.03 million +22.4%8.1%10.8 $16.26 1/15/20221,610,000 shares $25.33 million +10.3%6.6%7.9 $15.73 12/31/20211,460,000 shares $29.00 million No ChangeN/A0 $19.86 VTYX Short Interest - Frequently Asked Questions What is Ventyx Biosciences' current short interest? Short interest is the volume of Ventyx Biosciences shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 8,310,000 shares of VTYX short. 16.38% of Ventyx Biosciences' shares are currently sold short. Learn More on Ventyx Biosciences' current short interest. What is a good short interest ratio for Ventyx Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VTYX shares currently have a short interest ratio of 4.0. Learn More on Ventyx Biosciences's short interest ratio. What is a good short interest percentage for Ventyx Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.38% of Ventyx Biosciences' floating shares are currently sold short. Is Ventyx Biosciences' short interest increasing or decreasing? Ventyx Biosciences saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 8,310,000 shares, a decrease of 1.2% from the previous total of 8,410,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Ventyx Biosciences' float size? Ventyx Biosciences currently has issued a total of 70,500,000 shares. Some of Ventyx Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ventyx Biosciences currently has a public float of 50,740,000 shares. How does Ventyx Biosciences' short interest compare to its competitors? 16.38% of Ventyx Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Ventyx Biosciences: Xencor, Inc. (10.17%), Arcus Biosciences, Inc. (15.70%), Pacira BioSciences, Inc. (12.98%), Belite Bio, Inc (0.12%), Kiniksa Pharmaceuticals, Ltd. (5.62%), Akero Therapeutics, Inc. (12.05%), Spyre Therapeutics, Inc. (12.85%), ANI Pharmaceuticals, Inc. (0.97%), MannKind Co. (13.13%), AbCellera Biologics Inc. (9.58%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Ventyx Biosciences stock? Short selling VTYX is an investing strategy that aims to generate trading profit from Ventyx Biosciences as its price is falling. VTYX shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ventyx Biosciences? A short squeeze for Ventyx Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VTYX, which in turn drives the price of the stock up even further. How often is Ventyx Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VTYX, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Xencor Short Interest Data Arcus Biosciences Short Interest Data Pacira BioSciences Short Interest Data Belite Bio Short Interest Data Kiniksa Pharmaceuticals Short Interest Data Akero Therapeutics Short Interest Data Spyre Therapeutics Short Interest Data ANI Pharmaceuticals Short Interest Data MannKind Short Interest Data AbCellera Biologics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VTYX) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ventyx Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.